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Background: Prospective data on alcohol consumption, cigarette smoking and risk of head-neck cancer (HNC)
subtypes, i.e. oral cavity cancer (OCC), oro-/hypopharyngeal cancer (OHPC), and laryngeal cancer (LC), are limited.
We investigated these associations within the second largest prospective study on this topic so far, the Netherlands
Cohort Study.
Methods: 120,852 participants completed a questionnaire on diet and other cancer risk factors in 1986. After 17.3
years of follow-up, 395 HNC (110 OCC, 83 OHPC, and 199 LC) cases and 4288 subcohort members were available
for case-cohort analysis using Cox proportional hazards models.
Results: For total HNC, the multivariable adjusted incidence rate ratio (RR) was 2.74 (95% confidence interval (CI)
1.85-4.06) for those drinking ≥30 g ethanol/day compared with abstainers; in subtypes, RRs were 6.39 for OCC, 3.52
for OHPC, and 1.54 for LC. Compared with never cigarette smokers, current cigarette smokers had a RR of 4.49 (95%
CI 3.11-6.48) for HNC overall, and 2.11 for OCC, 8.53 for OHPC, and 8.07 for LC. A significant, positive, multiplicative
interaction between categories of alcohol consumption and cigarette smoking was found for HNC overall
(P interaction 0.03).
Conclusions: Alcohol consumption and cigarette smoking were independently associated with risk of HNC overall,
with a positive, multiplicative interaction. The strength of these associations differed among HNC-subtypes: OCC
was most strongly associated with alcohol consumption but most weakly with cigarette smoking, whereas LC was
not statistically significantly associated with alcohol consumption.
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Head and neck cancer (HNC) includes several malignan-
cies that originate in the paranasal sinuses, nasal cavity,
salivary glands, oral cavity, pharynx, and larynx [1]. HNC
is the seventh most common type of cancer in the world
and in the European Union; in Europe, HNC accounts for
an estimated 130,000 new cases every year [2].* Correspondence: denise.maasland@maastrichtuniversity.nl
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unless otherwise stated.Alcohol consumption and cigarette smoking are estab-
lished risk factors for HNC originating from the oral cav-
ity, pharynx, and larynx, and are likely to be differentially
associated with risk of those HNC-subtypes [3-8]. How-
ever, the majority of conducted studies are case-control
studies, a study design susceptible to misclassification with
regard to exposure. Prospective cohort studies are less
sensitive to this bias, but only six population-based cohort
studies have reported on alcohol consumption, cigarette
smoking and HNC-risk [9-15]. Of these studies, most had
a small number of cases and were thereby hardly able to
examine subtypes; HNC was often combined with other
cancers into upper aerodigestive tract cancer [9,12-15]. Inral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mation on smoking duration [10]. Finally, a greater than
multiplicative joint effect between alcohol and tobacco
consumption has been shown, but most evidence comes
from case-control studies as well [9,12-14,16-18].
Therefore, we wanted to investigate these associations in
HNC-subtypes within the large prospective Netherlands
Cohort Study (NLCS). We focused on the most frequent
HNC-subtypes: those located in the oral cavity, pharynx,
and larynx, and hypothesized that 1) alcohol consumption
and cigarette smoking are strongly, positively associated
with HNC-risk, with multiplicative interaction, and that
2) these risks are different for oral cavity cancer (OCC),
oro-/hypopharyngeal cancer (OHPC), and laryngeal cancer
(LC).
Methods
Design and study population
The present study was conducted within the NLCS,
which started in September 1986 with the inclusion of
120,852 participants, aged 55-69 years from 204 Dutch
municipal population registries [19].
For data processing and analysis, the case-cohort de-
sign was used for reasons of efficiency [20]. Cases were
derived from the total cohort, whereas the number of
person-years at risk for the total cohort was estimated
from a subcohort of 5000 persons, randomly sampled
from the entire cohort at baseline.
Follow-up for cancer incidence was done by annual
record linkage to the Netherlands Cancer Registry and
the nationwide network and pathology registry [21]. The
completeness of cancer follow-up is estimated to be ≥96%Figure 1 Flow diagram of the number of subcohort members and cas
and registry of histopathology and cytopathology in the Netherlands. aOral ca
or overlapping cancer; laryngeal cancer.[22], and follow-up for vital status of the subcohort was
nearly 100% complete after 17.3 years.
We excluded cohort members who reported to have
prevalent cancer other than skin cancer at baseline,
and cases and subcohort members with missing data
on exposure or confounding variables. Only micro-
scopically confirmed, first occurrences of squamous
cell carcinomas – which include nearly all malignancies of
the mouth, pharynx, and larynx [1,3] – of the head and
neck were included.
In total, 395 incident HNC cases and 4288 subcohort
members were available for analysis (Figure 1). Of these
cases, 110 were oral cavity cancer (ICD-O-3 C003-009,
C020-C023, C030-C031, C039-C041, C048-C050, C060-
C062, C068-C069), 83 oro-/hypopharyngeal cancer (C019,
C024, C051-C052, C090-C091, C098-C104, C108-C109,
C129-C132, C138-C139); 3 oral cavity, pharynx unspeci-
fied, or overlapping (C028-C029, C058-C059, C140-C142,
C148), and 199 laryngeal cancer (C320-C329) cases, clas-
sified as proposed by Hashibe et al. [23], according to
the International Classification of Diseases for Oncology
(ICD-O-3) [24].
The NLCS has been approved by the Medical Ethics
Committee of Maastricht University (Maastricht, The
Netherlands).
Exposure information
At baseline, all cohort members completed a self-
administered questionnaire, which included a 150-item
food frequency questionnaire (FFQ) with detailed ques-
tions on alcohol consumption, smoking habits, and other
cancer risk factors.es on whom the analyses were based. *PALGA: nationwide network
vity cancer; oro-/hypopharyngeal cancer; oral cavity, pharynx unspecified
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the year preceding the start of the study, measured by six
items: (1) beer; (2) red wine; (3) white wine; (4) sherry and
other fortified wines; (5) liquor types containing on aver-
age 16% alcohol; and (6) (Dutch) gin, brandy, and whisky.
In addition, questions were asked about the frequency of
consumption and the number of glasses consumed on
each drinking occasion. For analysis, we combined (2), (3),
and (4) into “wine”, and (5) and (6) into “liquor”. Total
mean daily ethanol intake was calculated using the Dutch
food-composition table [25]. On the basis of pilot study
data, standard glass sizes were defined as 200 mL for beer,
105 mL for wine, and 45 mL for liquor, corresponding to
8g, 10g, and 13g of ethanol, respectively [26]. We also
asked questions about the consumption of “beer” and
“other alcoholic beverages” 5 years before baseline and
selected participants with stable alcohol consumption to
perform a sensitivity analysis [27]. Participants who indi-
cated that they used alcoholic beverages never or less than
once a month were considered abstainers.
We asked detailed information regarding cigarette
smoking. Among others, questions were asked about
whether the subject was a smoker at baseline; age at
which they started and stopped smoking; the number of
cigarettes smoked daily and the number of smoking
years (excluding stopping periods). Based on these ques-
tions, the following variables were constructed for analysis:
smoking status (never/former/current); current smoking
(yes/no); frequency (cigarettes/day); duration (years); the
number of pack-years; and time since smoking cessation
(years). We also asked about cigar and pipe smoking and
the use of smokeless tobacco. Participants who indicated
they had never smoked cigarettes were considered never
smokers.
The FFQ was validated against a 9-day diet record,
and the Spearman correlation coefficient between the
alcohol intake assessed by the questionnaire and that
estimated by the diet record was 0.89 for all subjects
and 0.85 for users of alcoholic beverages [28]. The re-
producibility of the FFQ was assessed through annually
repeated measurements in a subgroup of the subcohort
and the test-retest correlation was 0.90 for alcohol
intake; this correlation declined only 0.01-0.02 per
year [29].
Data were key-entered and processed in a standardized
manner, blinded with regard to case/subcohort status
in order to minimize observer bias in coding and data
interpretation.
Data analysis
Person-years at risk were calculated from baseline until
diagnosis of HNC, death, emigration, loss to follow-up
or end of follow-up (i.e. 31 December 2003), whichever
occurred first.Age (years) and sex were considered predefined con-
founders. The potential confounders considered were
[3,30,31]: level of education, non-occupational physical
activity, energy intake, coffee and tea consumption, in-
take of fruit, vegetables, fish, fat, red meat, meat prod-
ucts, and family history of head-neck cancer. Alcohol
consumption and cigarette smoking were mutually ad-
justed in statistical models. A variable was considered a
confounder if including it in the model changed the rate
ratio (RR) for any of the cancer (sub-) types by >10%;
according to this, none of the potential confounders was
included in the final model.
The Cox proportional hazards model was used to esti-
mate incidence RRs and corresponding 95% confidence
intervals (CI) for alcohol consumption and cigarette
smoking in multivariable adjusted case-cohort analyses.
Analyses were done using the Stata 11.2 statistical soft-
ware package (StataCorp, College Station, Texas, USA).
Standard errors were calculated using the robust Huber-
White sandwich estimator to account for additional vari-
ance introduced by sampling from the cohort; this method
is equivalent to the variance-covariance estimator by
Barlow [32]. The proportional hazards (PH) assumption
was assessed using the scaled Schoenfeld residuals [33].
If there was an indication for violation of the assump-
tion for a variable, we further investigated this by adding
a time-varying covariate for that variable to the model.
We also analyzed beer, wine, and liquor consumption,
adjusted for ethanol intake, to examine whether substances
in alcoholic beverages, other than ethanol, have an effect
on HNC-risk. In smoking analyses, different aspects of
cigarette smoking were investigated and mutually adjusted
for, in order to obtain a complete exposure model. The
total number of cases that exclusively smoked cigar and/
or pipe or used smokeless tobacco was too low (N < 10) to
further analyze associations with HNC-risk.
When adjusting for smoking frequency, duration, or
pack-years, we centered these continuous variables as
proposed by Leffondré et al. [34]
Tests for linear dose-response trends were assessed by
fitting ordinal exposure variables as continuous terms.
To evaluate possible multiplicative interaction between
categories of alcohol consumption and cigarette smoking,
we estimated RRs of HNC overall and all HNC-subtypes
for combinations of these exposures. The interaction was
investigated by including cross-product terms in the
model and performing a Wald test. Two-sided P values
are reported throughout the article.
Tests for heterogeneity among HNC-subtypes were
performed to investigate differences between HNC sub-
types by a bootstrapping method developed for the
case-cohort design [35]. For each bootstrap sample, X
subcohort members were randomly drawn from the
subcohort of X subjects and Y cases from the total of Y
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of the dataset of X + Y observations. The logHRs were
obtained from this sample using Stata’s competing risks
procedure and recalculated for each bootstrap-replication.
The confidence interval and P value of the differences in
hazard ratio of the subtypes were then calculated from the
replicated statistics. Each bootstrap analysis was based on
at least 1,000 replications [36].
Results
Compared to the subcohort, cases were more frequently
men than women, and less often alcohol abstainers
(Table 1). Among alcohol consumers, cases had a sub-
stantially higher alcohol intake and generally drank more
beer, wine, and liquor than subcohort members. In both
cases and subcohort members, men mostly consumed
beer and liquor, whereas women drank more wine. With
respect to cigarette smoking, cases were far more often
current smokers and also smoked a substantially higher
number of pack-years than subcohort members. Women
were more often never smokers than men; among ever
smokers, men generally smoked more pack-years than
women, in cases and subcohort members.
Alcohol consumption
Alcohol consumption of ≥30 grams (g) per day com-
pared with abstinence was associated with a statistically
significantly increased risk of HNC overall (multivariate
RR = 2.74, 95% CI 1.85-4.06), OCC (RR = 6.39, 95% CI
3.13-13.03), and OHPC (RR = 3.52, 95% CI 1.69-7.36),
but not LC (RR = 1.54, 95% CI 0.91-2.60) (Table 2). A
strong dose-response relationship (P trend < 0.001) was
found between categories of increasing alcohol consump-
tion and HNC overall, OCC, and OHPC risk. A significant
interaction was found between sex and continuous alco-
hol consumption in HNC overall (P = 0.02) and OCC
(P = 0.004), with women having higher RRs than men.
After adjustment for total alcohol intake, consumption
of beer, wine, and liquor was generally not significantly
associated with HNC-risk. Beer consumption was, how-
ever, statistically significantly, positively associated with
OHPC-risk (P trend = 0.03); liquor consumption was
significantly associated with an increased risk of OCC
(P trend = 0.03). Wine consumption was largely inversely
associated – although not statistically significantly – with
risk of HNC overall and HNC-subtypes.
Although risk rates clearly varied among HNC-subtypes,
tests for heterogeneity did not show any significant risk
differences, possibly due to low power.
Cigarette smoking
Current cigarette smoking was statistically significantly
associated with risk of HNC overall (multivariate RR =
4.49, 95% CI 3.11-6.48) and all subtypes, with strongestassociations in OHPC (RR = 8.53, 95% CI 3.38-21.55)
and LC (RR = 8.07, 95% CI 3.94-16.54), compared with
never smoking (Table 3). Compared with never smok-
ing, former cigarette smoking was also associated with
risk of HNC overall, although not statistically signifi-
cantly (RR = 1.44, 95% CI 0.97-2.14), OHPC (RR = 2.68,
95% CI 1.00-7.14), and LC (RR = 2.63, 95% CI 1.26-5.47),
but not OCC (RR = 0.70, 95% CI 0.37-1.33). Frequency
and duration of cigarette smoking were also strongly,
statistically significantly associated with an increased
risk of HNC overall, OHPC, and LC (Table 3).
Regarding different aspects of cigarette smoking,
after mutual adjustment, cigarette smoking status, fre-
quency, and duration all remained statistically signifi-
cantly associated with risk of HNC overall, OHPC, and
LC (see Additional file 1). After additional adjustment
for alcohol consumption (Table 3), most RRs between
cigarette smoking status, frequency, duration and risk
of HNC(-subtypes) slightly attenuated, but remained
statistically significantly associated with increased
risks.
Results regarding smoking cessation show that the risk
of HNC overall and all subtypes diminished for smokers
who stopped smoking since <10, 10 to <20, or ≥20 years,
compared with current smokers (all P trend < 0.01)
(Table 3). Nevertheless, compared with never smokers,
RRs 20 years after smoking cessation were still elevated
for HNC overall, OHPC, and LC, although not statisti-
cally significantly.
Despite considerable differences in risk rates among
HNC-subtypes, tests for heterogeneity only showed sta-
tistically significant risk rates for duration of cigarette
smoking (P < 0.001) and time since smoking cessation
(P < 0.001).
Interaction between alcohol consumption and cigarette
smoking
For HNC overall, increased risks were found for every ex-
posure combination of alcohol consumption and cigarette
smoking, mostly statistically significantly, compared to
never smokers and abstainers as reference group (Table 4).
In addition, a statistically significant, positive, multiplica-
tive interaction was found (P interaction 0.03) between
categories of alcohol consumption and cigarette smoking,
with a RR of 8.28 (95% CI 3.98-17.22), comparing partici-
pants smoking ≥ 20 cigarettes and drinking ≥30 g alcohol
per day with never smokers abstaining from alcohol.
In HNC-subtypes, RRs were mostly increased as well
when comparing participants smoking ≥ 20 cigarettes and
drinking >15 g alcohol per day with never smokers con-
suming 0 to 15g alcohol per day, with the highest RR for
OHPC (RR = 16.12, 95% CI 4.31-60.27), but no significant
interaction was found, possibly due to low numbers in
strata.
Table 1 Characteristics of cases and subcohort members in the Netherlands Cohort Study (NLCS), 1986 - 2003
Subcohort Head-neck cancer cases
Overall Subtypes
OCCa OHPCa LCa
Exposure variables and potential confounders (N = 4288)b (N = 395)b (N = 110)b (N = 83)b (N = 199)b
Age at baseline (years) 61.3 (4.2)c 61.8 (4.1) 61.8 (4.3) 61.5 (4.2) 61.8 (4.0)
Sex: men (%) 49.2 79.5 59.1 73.5 94.0
Abstainer from alcohol (%) 23.9 12.4 10.9 13.3 13.1
Men (%) 14.8 9.2 4.6 9.8 10.7
Women (%) 32.6 24.7 20.0 22.7d 50.0e
Alcohol consumers:
Ethanol intake (grams/day) 13.4 (15.0) 27.3 (25.6) 28.7 (25.4) 35.0 (31.6) 23.2 (22.1)
Men 17.5 29.1 34.3 40.2 23.5
Women 8.5 18.6 19.1 18.0 14.7
Beer intake (glasses/week) 2.2 (5.8) 6.3 (12.5) 4.4 (10.2) 10.3 (18.3) 5.8 (10.4)
Men 3.7 6.9 6.1 11.1 5.8
Women 0.3 3.5 1.4 7.9 4.5
Wine intake (glasses/week) 3.7 (5.6) 4.4 (9.1) 5.5 (8.1) 6.0 (11.5) 3.1 (8.4)
Men 3.1 4.0 4.2 6.7 3.1
Women 4.4 6.0 7.7 3.5 4.1
Liquor intake (glasses/week) 2.9 (5.7) 7.3 (10.0) 8.4 (11.2) 7.7 (11.7) 6.4 (8.3)
Men 4.6 8.2 11.5 9.4 6.6
Women 0.9 3.0 3.1 1.9 1.9
Cigarette smoking status
Total
Never smokers (%) 36.9 11.1 26.4 7.2 4.5
Former smokers (%) 35.5 27.9 21.8 26.5 32.2
Current smokers (%) 27.6 61.0 51.8 66.3 63.3
Men
Never smokers (%) 13.8 6.7 16.9 4.9 3.7
Former smokers (%) 51.4 31.5 27.7 29.5 33.7
Current smokers (%) 34.8 61.8 55.4 65.6 62.6
Women
Never smokers (%) 59.4 28.4 40.0 13.6d 16.7e
Former smokers (%) 20.0 13.6 13.3 18.2 8.3
Current smokers (%) 20.6 58.0 46.7 68.2 75.0
Ever cigarette smokers:
Frequency of cigarette smoking (N/day) 15.3 (10.2) 19.5 (10.9) 19.9 (11.9) 21.4 (12.7) 18.6 (9.6)
Men 17.1 19.9 21.6 22.9 18.4
Women 11.6 17.4 16.5 16.7 22
Duration of cigarette smoking (years) 31.7 (12.1) 39.1 (9.5) 37.8 (9.2) 38.5 (9.8) 39.9 (9.4)
Men 33.6 39.8 38.9 39.8 40.0
Women 27.8 35.8 35.4 34.5 38.2
Pack-years of cigarette smoking (N) 22.8 (17.7) 34.4 (20.9) 34.5 (23.5) 37.0 (23.2) 33.5 (18.9)
Men 26.2 35.7 38.5 40.5 33.2
Women 16.0 28.3 26.4 26.3 38.5
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Table 1 Characteristics of cases and subcohort members in the Netherlands Cohort Study (NLCS), 1986 - 2003
(Continued)
Level of education (%)
Primary 29.5 27.6 20.9 25.6 31.5
Lower vocational 22.0 18.9 17.3 17.1 20.8
Secondary and medium vocational 34.8 35.7 41.8 36.6 32.5
University and higher vocational 13.8 17.9 20.0 20.7 15.2
aOCC: oral cavity cancer; OHPC: oro-/hypopharyngeal cancer; LC: laryngeal cancer.
bThe number of subcohort members or cases used in age- and sex-adjusted, multivariate analyses of alcohol consumption and cigarette smoking.
cValues are given as mean (SD); for categorical variables, N (%) is presented.
dBased on only 22 female OHPC cases.
eBased on only 12 female LC cases.
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In this large prospective study on alcohol consumption,
cigarette smoking, and risk of HNC(-subtypes), alcohol
consumption and cigarette smoking were strongly, inde-
pendently associated with an increased risk of HNC
overall. The strength of these associations however dif-
fered between HNC-subtypes; OCC was most strongly
associated with alcohol consumption but most weakly
with cigarette smoking, whereas LC was not statistically
significantly associated with alcohol consumption. For
HNC overall, a multiplicative interaction between cat-
egories of alcohol consumption and cigarette smoking
was found.
Alcohol consumption
Our results are in agreement with those of previous
studies, showing alcohol consumption to be an independ-
ent risk factor for the development of HNC, with a strong,
dose-response relationship [4,9,11-14,17,23,37,38]. Alco-
holic beverages and acetaldehyde, the main metabolite of
ethanol, are classified as a class I carcinogen [18]. It is
plausible that alcohol – after being metabolized – acts
both directly and indirectly in HNC carcinogenesis, the
latter for example by acting as a solvent for other possible
carcinogens, such as tobacco carcinogens [3,39].
The differential risk among HNC-subtypes is consistent
with other studies, in which LC was also least associated
with alcohol consumption [8,40,41]. However, several
other studies found OHPC being most associated with
alcohol consumption, although sometimes in specific
subgroups, as opposed to OCC in our study [11,23,41].
Nevertheless, the differential risk among HNC-subtypes
is likely to be explained by the larynx having the least
direct exposure to alcohol compared with the oral cavity
and pharynx [39,42]. The slightly increased RRs for al-
cohol consumption and LC may be due to inhalation of
alcohol containing aerosols, silent aspiration, systemic
effects, and possibly residual confounding.
After adjustment for total alcohol intake, we generally
found similar risks between intake of beer, wine, liquorand HNC. These findings imply that ethanol itself prob-
ably is the most important factor in determining HNC-
risk, rather than other substances in alcoholic bever-
ages, which is in line with the results from other studies
[3,11,42]. Consumption of wine was, however, generally
inversely associated with HNC-risk, as was also shown
in a pooled analysis [42], which could be due to residual
confounding by a general healthier lifestyle of wine-
consumers in our study population [3,42,43].
The significantly higher RRs between alcohol consump-
tion and HNC risk in women as compared with men were
seen earlier and could possibly be explained by women
having stronger carcinogenic effects of alcohol at the same
exposure level, suggesting possible gender-specific risk or
protective factors [11].
Cigarette smoking
This study confirms the strong associations of cigarette
smoking with increased risk of HNC overall and all sub-
types [3,5,7,10,14,23,37,41]. Among subtypes, however,
OCC was least associated with cigarette smoking, and
strongest associations were found with OHPC and LC.
In addition, smoking status, frequency, and duration all
appear to be of importance in the association between
cigarette smoking and risk of HNC overall, OHPC, and
LC. These results are generally consistent with previous
reviews showing that cigarette smoking has a stronger
effect on the larynx and/or pharynx than on the oral
cavity [7,8,10,23,41]; in two meta-analyses, the larynx
seemed to be clearly most susceptible to the effects of
cigarette smoking [23,41]. A possible explanation for
this could be the aerodynamics of respiratory flow in
the upper airway: this flow changes from laminar in the
oral cavity to turbulent in the larynx, which may result
in the larynx and pharynx having a higher exposure to
inhaled air - and thus to cigarette smoke - than the oral
cavity.
Finally, our study shows smoking cessation leads to
decreased HNC-risks, which is in line with results from
a recent pooled analysis as well [44].
Table 2 Associations (multivariablea adjusted incidence RRs) between alcohol consumption and risk of subtypes of head-neck cancer; Netherlands Cohort
Study (NLCS), 1986 – 2003







No. of cases RR (95% CI) No. of cases RR (95% CI) No. of cases RR (95% CI) No. of cases RR (95% CI) P for
heterogeneity
Alcohol consumption (grams ethanol/day)
Abstainers 0 15 255 49 1 (reference) 12 1 (reference) 11 1 (reference) 26 1 (reference) 0.86
>0 to <5 2 19 008 67 1.11 (0.75-1.65) 17 1.25 (0.59-2.65) 14 1.06 (0.47-2.40) 36 1.03 (0.60-1.77)
5 to <15 9 14 468 72 1.15 (0.77-1.71) 19 1.91 (0.91-4.03) 12 0.90 (0.38-2.13) 40 0.94 (0.56-1.58)
15 to <30 22 9 961 92 1.52 (1.02-2.27) 30 3.88 (1.86-8.12) 13 0.99 (0.41-2.38) 49 1.10 (0.66-1.83)
≥30 40 5 659 115 2.74 (1.85-4.06) 32 6.39 (3.13-13.03) 33 3.52 (1.69-7.36) 48 1.54 (0.91-2.60)
P for trendc <0.001 <0.001 <0.001 0.05
Continuous, 10 gram
ethanol/day increments
Overall 64 352 395 1.20 (1.12-1.27) 110 1.28 (1.18-1.39) 83 1.27 (1.16-1.38) 199 1.10 (1.02-1.18) 0.18
Men 30 169 314 1.19 (1.12-1.27) 65 1.27 (1.17-1.38) 61 1.27 (1.16-1.39) 187 1.10 (1.03-1.19)
Women 34 183 81 1.40 (1.18-1.65) 45 1.58 (1.33-1.87) 22 1.31 (0.91-1.87) 12 0.85 (0.46-1.59)
P for interactiond 0.02 0.004 0.68 0.67
Alcohol consumption (grams ethanol/day) stable userse
Abstainers 0 11 810 38 1 (reference) 9 1 (reference) 9 1 (reference) 20 1 (reference) 1.00
>0 to <5 2 11 813 36 0.98 (0.60-1.61) 12 1.65 (0.68-4.01) 7 0.86 (0.30-2.41) 17 0.72 (0.35-1.46)
5 to <15 9 8 749 38 0.96 (0.58-1.59) 9 1.68 (0.63-4.47) 8 0.89 (0.32-2.47) 21 0.72 (0.37-1.40)
15 to <30 22 5 293 45 1.27 (0.76-2.11) 12 3.20 (1.25-8.19) 6 0.72 (0.23-2.26) 27 0.96 (0.50-1.83)
≥30 42 3 047 69 2.90 (1.78-4.73) 17 7.50 (3.15-17.88) 20 3.46 (1.46-8.20) 31 1.57 (0.82-3.02)
P for trend <0.001 <0.001 0.001 0.03




No beer 0 43 519 183 1 (reference) 59 1 (reference) 36 1 (reference) 87 1 (reference) 0.84
>0- < 1 0.2 16 408 129 0.94 (0.71-1.24) 34 1.10 (0.65-1.86) 24 0.98 (0.54-1.76) 69 0.85 (0.60-1.22)


















Table 2 Associations (multivariablea adjusted incidence RRs) between alcohol consumption and risk of subtypes of head-neck cancer; Netherlands Cohort
Study (NLCS), 1986 – 2003 (Continued)
≥2 3.4 1 554 46 1.39 (0.83-2.34) 9 0.99 (0.34-2.82) 17 2.48 (1.03-5.98) 20 1.30 (0.69-2.46)
P for trend 0.14 0.95 0.03 0.20
Continuous, 1 64 335 395 1.07 (0.97-1.19) 110 0.97 (0.80-1.16)g 83 1.19 (1.01-1.40) 199 1.08 (0.96-1.23) 0.07
glass/day increments
Wine
No wine 0 30 263 197 1 (reference) 44 1 (reference) 38 1 (reference) 114 1 (reference) 0.93
>0- < 1 0.2 25 975 132 0.88 (0.67-1.14) 40 1.07 (0.67-1.71) 33 1.01 (0.59-1.75) 57 0.74 (0.52-1.05)
1- < 2 1.4 5 277 39 0.95 (0.63-1.44) 14 1.31 (0.67-2.55) 5 0.52 (0.19-1.39) 20 1.07 (0.63-1.83)
≥2 2.6 2 751 24 0.56 (0.29-1.07) 11 0.93 (0.34-2.57) 7 0.52 (0.15-1.81)g 6 0.39 (0.15-0.99)
P for trend 0.15 0.93 0.16 0.21
Continuous, 1 64 265 392 0.88 (0.74-1.05) 109 0.89 (0.69-1.16) 83 0.86 (0.64-1.17) 197 0.88 (0.68-1.14) 0.26
glass/day increments
Liquor
No liquor 0 33 299 137 1 (reference) 40 1 (reference) 34 1 (reference) 63 1 (reference) 0.44
>0- < 1 0.2 23 492 133 1.09 (0.84-1.43) 31 1.10 (0.67-1.80) 23 0.86 (0.48-1.53) 78 1.17 (0.81-1.67)
1- < 2 1.9 5 370 67 1.09 (0.76-1.57) 18 1.65 (0.87-3.15) 12 0.79 (0.39-1.62) 37 1.08 (0.67-1.74)
≥2 2.8 2 115 56 1.18 (0.71-1.95) 20 2.26 (1.02-4.99) 14 0.83 (0.33-2.13) 20 0.95 (0.47-1.93)
P for trend 0.61 0.03 0.64 0.83
Continuous, 1 64 275 393 1.01 (0.86-1.18) 109 1.18 (0.89-1.56) 83 0.89 (0.68-1.15) 198 0.98 (0.80-1.21) 0.25
glass/day increments
aAdjusted for age (years), sex, cigarette smoking (status (never/former/current), frequency (continuous; centered), and duration (continuous; centered)).
bOCC: oral cavity cancer; OHPC: oro-/hypopharyngeal cancer; LC: laryngeal cancer.
cTests for dose-response trends were assessed by fitting ordinal variables as continuous terms in the Cox proportional hazards model.
dP Value for interaction between sex and alcohol consumption, based on cross-product terms in the Cox proportional hazards model and Wald test.
eSubjects who had not changed their continuous alcohol consumption habits in the 5 years before baseline: for “beer” and “other alcoholic beverages”, participants could indicate whether 5 years before baseline they
drunk (1) more than, (2) equal amounts of or (3) less than at baseline; the fourth answer option was (4) “I never use this”.
fAdditionally adjusted for continuous ethanol intake (g ethanol/day).


















Table 3 Associations (multivariablea adjusted incidence RRs) between cigarette smoking and risk of subtypes of head-neck cancer; Netherlands Cohort Study
(NLCS), 1986 - 2003









RR (95% CI) No. of
cases
RR (95% CI) No. of
cases
RR (95% CI) No. of
cases
RR (95% CI) P for
heterogeneity
Cigarette smoking status
Never smokers 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) 0.97
Former smokers 22644 110 1.44 (0.97-2.14) 24 0.70 (0.37-1.33) 22 2.68 (1.00-7.14)i 64 2.63 (1.26-5.47)
Current smokers 16657 241 4.49 (3.11-6.48) 57 2.11 (1.23-3.62) 55 8.53 (3.38-21.55) 126 8.07 (3.94-16.54)
P for trendc <0.001 0.001 <0.001 <0.001
P for interaction with sexd 0.25 0.08 0.44 0.46
Cigarette smoking status, additionally adjusted for frequency and duration of cigarette smokinge
Never smokers 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) 0.97
Former smokers 22644 110 1.64 (1.08-2.49) 24 0.79 (0.40-1.58) 22 3.03 (1.09-8.45) 64 2.87 (1.34-6.13)
Current smokers 16657 241 3.51 (2.36-5.23) 57 1.91 (1.06-3.42) 55 7.49 (2.87-19.54) 126 5.26 (2.45-11.28)
P for trend <0.001 0.03 <0.001 <0.001
Frequency of cigarette smoking (N/day)f
Never smokers 0 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) 0.99
>0 to <20 10 24787 155 1.30 (0.84-2.01) 38 0.63 (0.30-1.32) 30 2.08 (0.73-5.94) 85 2.32 (1.07-5.04)
≥20 20 14514 196 2.23 (1.45-3.44) 43 1.06 (0.52-2.16) 47 4.67 (1.64-13.34) 105 3.75 (1.73-8.14)
P for trend <0.001 0.33 <0.001 <0.001
Continuous, 10 cigarettes/day increments 64352 395 1.25 (1.13-1.38) 110 1.20 (1.00-1.44)j 83 1.42 (1.20-1.69) 199 1.21 (1.08-1.36) 0.71
Duration of cigarette smoking (years)g
Never smokers 0 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) <0.001
>0 to <20 13 7433 20 1.00 (0.56-1.77) 4 0.38 (0.13-1.17) 5 2.11 (0.59-7.51) 11 1.88 (0.75-4.69)
20 to <40 30 18999 105 1.44 (0.95-2.21) 30 0.80 (0.41-1.59) 25 2.74 (0.98-7.68) 50 2.35 (1.09-5.06)
≥40 43 12868 226 2.45 (1.49-4.02) 47 0.98 (0.39-2.46) 47 3.89 (1.22-12.40) 129 4.81 (2.11-11.00)
P for trend <0.001 0.87 0.02 <0.001
Continuous, 10 years increments 64352 395 1.28 (1.14-1.42) 110 1.03 (0.85-1.24) 83 1.36 (1.09-1.70) 199 1.49 (1.25-1.78) 0.25
Pack-years of cigarette smokingh
Never smokers 0 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) 1.00


















Table 3 Associations (multivariablea adjusted incidence RRs) between cigarette smoking and risk of subtypes of head-neck cancer; Netherlands Cohort Study
(NLCS), 1986 - 2003 (Continued)
20 to <40 28 12732 132 1.65 (1.04- 2.60) 32 0.84 (0.39-1.83) 26 2.87 (0.94-8.79) 73 2.93 (1.33-6.48)
≥40 48 5736 123 2.82 (1.76-4.50) 25 1.28 (0.58-2.82) 31 6.49 (2.11-19.95) 66 4.79 (2.15-10.64)
P for trend <0.001 0.07 <0.001 <0.001
Continuous, 10 pack-years increments 64352 395 1.18 (1.11-1.25) 110 1.16 (1.04-1.28) 83 1.24 (1.12-1.36) 199 1.16 (1.09-1.24) 0.77
Cigarette smoking cessationi
Never smokers 25 25051 44 1 (reference) 29 1 (reference) 6 1 (reference) 9 1 (reference) <0.001
Stopped ≥20 years 14 6953 24 1.25 (0.72-2.19) 5 0.63 (0.22-1.81) 6 3.35 (0.97-11.55) 13 1.92 (0.79-4.70)
Stopped 10 to <20 years 5 7717 36 1.49 (0.91-2.43) 8 0.78 (0.32-1.86) 8 3.29 (1.04-10.39) 20 2.45 (1.07-5.61)k
Stopped >0 to <10 years 0 7918 50 1.73 (1.09-2.76) 11 0.84 (0.39-1.83) 8 2.48 (0.77-7.93) 31 3.45 (1.56-7.62)
Current smokers 16657 241 4.26 (2.93-6.20) 57 2.03 (1.16-3.56) 55 8.10 (3.14-20.87) 126 7.53 (3.65-15.51)
P for trend <0.001 0.004 <0.001 <0.001
aAll analyses were adjusted for age (years), sex, and alcohol consumption (g ethanol/day; continuous).
bOCC: oral cavity cancer; OHPC: oro-/hypopharyngeal cancer; LC: laryngeal cancer.
cTests for dose-response trends were assessed by fitting ordinal variables as continuous terms in the Cox proportional hazards model.
dP Value for interaction between sex and cigarette smoking status, based on cross-product terms in the Cox proportional hazards model and Wald test.
eAdditionally adjusted for frequency (N/day; continuous; centered) and duration of cigarette smoking (years; continuous; centered).
fAnalyses of cigarette smoking frequency were additionally adjusted for current cigarette smoking and duration of cigarette smoking (years; continuous; centered).
gAnalyses of cigarette smoking duration were additionally adjusted for current cigarette smoking and frequency of cigarette smoking (N/day; continuous; centered).
hAnalyses of cigarette smoking pack-years were additionally adjusted for current cigarette smoking.
iCigarette smoking cessation was additionally adjusted for the no. of cigarette pack-years (continuous; centered).
jP < 0.05.


















Table 4 Combinations of categories of alcohol consumption and cigarette smoking and risk (multivariablea adjusted incidence RRs) of subtypes of head-neck




Alcohol consumption (grams ethanol/day) Alcohol consumptionc Alcohol consumptionc Alcohol consumptionc
0 >0 to <5 5 to <15 15 to <30 ≥30 0-15 >15 0-15 >15 0-15 >15
Frequency of cigarette smoking (N/day)
Never smokers
Cases/person time at riskd 10/8959 13/9729 7/4245 11/1499 3/619 21/22933 8/2118 3/22933 3/2118 6/22933 3/2118
RR 1 (ref) 1.20 1.23 5.53 2.97 1 (ref) 4.16 1 (ref) 10.18 1 (ref) 3.05
95% CI 0.52 – 2.75 0.46 – 3.29 2.27 – 13.49 0.78 – 11.40 1.82 – 9.52 2.03 – 51.06 0.72 – 12.92
>0 to <20
Cases/person time at risk 21/4194 25/6534 37/7061 40/4814 32/2184 20/17789 18/6998 18/17789 12/6998 44/17789 41/6998
RR 1.89 1.56 2.04 2.63 3.81 0.76 1.55 4.02 5.63 2.66 4.19
95% CI 0.83 – 4.34 0.71 – 3.41 0.95 – 4.40 1.22 – 5.67 1.71 – 8.51 0.34 – 1.71 0.66 – 3.62 1.07 – 15.14 1.44 – 22.00 1.03 – 6.86 1.60 – 11.02
≥20
Cases/person time at risk 18/2102 29/2745 28/3162 41/3648 80/2856 7/8010 36/6504 16/8010 31/6504 52/8010 53/6504
RR 2.78 3.88 2.85 3.32 8.28 0.58 3.54 7.26 16.12 5.42 5.54
95% CI 1.18 – 6.54 1.77 – 8.49 1.28 – 6.34 1.52 – 7.25 3.98 – 17.22 0.21 – 1.58 1.66 – 7.52 1.86 – 28.44 4.31 – 60.27 2.10 – 13.98 2.15 – 14.27
P for interactione 0.03 0.10 0.09 0.19
aAdjusted for age, sex, current cigarette smoking, and duration of cigarette smoking (years; continuous; centered).
bOCC: oral cavity cancer; OHPC: oro-/hypopharyngeal cancer; LC: laryngeal cancer.
cFor the categorical interaction analyses in HNC-subtypes, it was necessary to aggregate categories of alcohol consumption (grams ethanol/day) in order to obtain sufficient numbers in strata.
dPerson time at risk in years.
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Our study confirms a multiplicative interaction between
categories of alcohol consumption and cigarette smoking
in HNC overall [9,14,16-18,37,38,41]. The interaction
effect between alcohol consumption and cigarette
smoking is biologically plausible, since alcohol can act as
a solvent for carcinogens in cigarette smoke and make the
mucosa more permeable for these carcinogens; as a
result, the carcinogenic properties of both factors are
likely to be enhanced in the presence of one another
[3,39]. Still, in HNC-subtypes, we had low numbers of
cases in strata, which probably resulted in limited power
to detect a significant deviation from the multiplicative
model.
Strengths and limitations
Important strengths of our study are the prospective
character and completeness of follow-up. Our study is
the second largest prospective cohort study investigating
alcohol consumption and cigarette smoking on the risk
of HNC overall and subtypes so far [9-15]. Furthermore,
we were able to take into account data on smoking
duration, and to investigate as well as adjust for several
aspects of smoking behavior.
A possible limitation of our study is the single measure-
ment of exposure data. Alcohol consumption and cigarette
smoking were however extensively addressed in the ques-
tionnaire, with questions about lifetime exposure history
of smoking and alcohol intake 5 years before baseline. It is
however possible that participants who smoked at baseline
in 1986 stopped smoking at some point during follow-up
or changed their alcohol intake, and this may have led to
bias due to misclassification. Furthermore, although our
study includes a large number of cases, a lack of power is
a possible explanation for finding non-significant results
for some associations and the tests for heterogeneity.
We lack information on human papillomavirus (HPV)
infection. HPV-infection is associated with HNC-risk
[45,46], but mainly with OHPC, in particular tonsil can-
cer and cancer of the base of the tongue. According to
rates in our university medical center, only 25% of the
diagnosed and treated oropharyngeal cancers between
1997 and 2003 were HPV-positive (all oropharyngeal
cancer cases have been analyzed by p16-immunostaining
and HPV16-specific fluorescence in situ hybridization
(FISH), and – if FISH was negative – HPV-specific poly-
merase chain reaction). Moreover, the role of HPV in
HNC-carcinogenesis is mainly of importance in young
HNC-patients, and has increased since 1990 [47-49].
Since our participants were aged 55-69 years at baseline
in 1986, we assume that the number of HPV-associated
HNC cases in our cohort is low, and we expect potential
bias due to possible misclassification to be very limited.Other factors we did not take into account in our ana-
lyses are the use of drugs and oral hygiene. Although we
investigated several potential confounders, residual con-
founding is still possible, but we presume this to be limited
as well.
It might also be interesting to examine the RRs of HNC
for smokers among non-drinkers and for drinkers among
non-smokers. However, as the case numbers for these
subgroups would be too small to analyze, we decided not
to investigate this.
Finally, though we wanted to examine the role of alcohol
consumption and cigarette smoking in HNC-subtypes, we
did not investigate HNC located in the major salivary
glands, nasal cavity, paranasal sinuses, and nasopharynx,
because of low numbers of these cases as well as a pre-
sumably different etiology [50].
Conclusions
In conclusion, the present study, which is the second lar-
gest prospective cohort study regarding this topic so far,
confirms the principal role of alcohol consumption and
cigarette smoking in HNC-carcinogenesis, as well as the
differential associations with HNC-subtypes, and a sig-
nificant, positive, multiplicative interaction between both
factors. As the existing evidence is largely based on case-
control studies, this cohort study contributes to establish
in which extent alcohol consumption and cigarette smok-
ing are associated with risk of HNC overall and, more spe-
cifically, HNC-subtypes.
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